Evotec purchasing Galapagos' compound management business, Compound Focus Inc., for $14.7 million in cash, plus $3.3 million in milestones

Galapagos N.V.

Belgium / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Evotec AG

Germany / Small-Cap Biopharma (<$1 billion)

$410.8m on 05/27/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced